BENSALEM, Pa.–(BUSINESS WIRE)–$IRTC–Law Offices of Howard G. Smith continues its investigation on behalf of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC) investors concerning the Company and its officers’ possible violations of federal securities laws.
Between March 13 and March 27, 2019, a series of reports alleged that the Company’s revenue base relied on “an exceedingly generous, but increasingly fragile, reimbursement regime.” These reports also alleged that the Company engaged in deceptive accounting practices.
On this news, iRhythm’s stock price fell $14.02 per share, or over 16%, over several trading sessions to close at $73.24 on March 28, 2019, thereby injuring investors.
Then, on November 13, 2019, iRhythm disclosed that it could not timely file its quarterly report, citing accounting errors affecting prior periods that require further analysis. The Company stated that “[t]hese errors may result in the correction of previously issued annual and quarterly financial statements” and “the error evaluation will include the assessment of any additional control deficiencies.”
On this news, iRhythm’s stock price fell $4.38, or over 6% to close at $63.04 on November 13, 2019, thereby injuring investors further.
If you purchased iRhythm securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to firstname.lastname@example.org, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.